MUNICH--(BUSINESS WIRE)--Definiens, the pioneer in Tissue Phenomics solutions for diagnostics development and commercialization, today announced that chief commercial officer Merrilyn Datta, PhD, will present at Rational Combinations 360°, being held in New York, NY from June 23-24, 2016. The event will bring together pharmaceutical and biotech companies seeking to accelerate clinical trials in the immuno-oncology space to discuss novel trial designs, and business and scientific developments for combination immunotherapies.
